Advertisement
Advertisement
UNCY
Unicycive Therapeutics, Inc. Common Stock
0.571
USD-0.05
-7.44%
Feb 24, 15:57 UTC -5
Closed
After-Market
0.571
0
0.00%
Unicycive Therapeutics, Inc. Common Stock Profile
About
Info & Links
CEO
Shalabh Gupta
Headquarters
LOS ALTOS, CA 94022, UNITED STATES
Industry
Sector
Website
Auditor
Mayer Hoffman McCann PC
Share holders
109
Employees
14
Unicycive Therapeutics, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
59.27M
Enterprise Value
26.92M
Enterprise Value/EBITDA(ttm)
-0.94
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
2.07
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
209.35%
Return on Assets(ttm)
-29.88%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-28.79M
Net Income Available to Common(ttm)
-30.02M
Diluted EPS(ttm)
-0.97
Share Statistics
Beta (5Y Monthly)
2.24
52-Week Change
-68.10%
S&P 500 52-Week Change
18.47%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
103.80M
Dividend Yield
0.00%
Float4
78.78M
% Held by Insiders
24.10%
% Held by Institutions
40.42%
Balance Sheet
Total Cash(mrq)
32.35M
Total Cash Per Share(mrq)
0.31
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
3.61%
Quick Ratio(mrq)
3.61%
Book Value Per Share(mrq)
0.28
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.25
Free Cash Flow(ytd)
-22.08M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement